Related references
Note: Only part of the references are listed.Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults
Pauline Byakika-Kibwika et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients:: Pharmacogenetic effect of CYP2B6 variation
Awewura Kwara et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene
Federico Innocenti et al.
PHARMACOGENETICS AND GENOMICS (2008)
Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART
Xaviere Panhard et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes
Vincent C. Peterkin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults
Mina C. Hosseinipour et al.
AIDS (2007)
Identification of a novel 974C→G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids
Christophe Corpechot et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
Peter L. Anderson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India
HE Vezina et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P4502B6 in human liver microsomes
LM Hesse et al.
PHARMACOGENETICS (2004)
The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities
PL Anderson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV infected individuals
PL Anderson et al.
AIDS (2003)
Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism
MH Court et al.
DRUG METABOLISM AND DISPOSITION (2003)
Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection
NL Rezk et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Regulation of drug and bile salt transporters in liver and intestine
GA Kullak-Ublick et al.
DRUG METABOLISM REVIEWS (2003)
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients
M Holthe et al.
PHARMACOGENOMICS JOURNAL (2003)
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons
CV Fletcher et al.
AIDS (2000)
Share Paper
